enGene Inc. (ENGN)
NASDAQ: ENGN
· Real-Time Price · USD
4.00
0.20 (5.26%)
At close: Aug 20, 2025, 10:12 AM
enGene Income Statement
Financials in USD. Fiscal
year is
November - October.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 82K | 160K | 240K | 240K | 158K | 80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -82K | -160K | -240K | -240K | -158K | -80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -33.7M | -78.14M | -62.3M | -55.28M | -44.77M | -32.2M | -26.06M | -22.16M | -21.21M | -20.71M | -16.08M | -9.54M | -4.23M | n/a |
Interest Income | 6.65M | 12.12M | 10.41M | 7.8M | 4.81M | 1.98M | 1.12M | 779K | 415K | 285K | 124.91K | 55.91K | 25.91K | 6.91K |
Pretax Income | -28.48M | -69.02M | -55.16M | -122.36M | -112.9M | -103.22M | -99.9M | -25.76M | -27.79M | -27.83M | -20.63M | -12.29M | -5.54M | -215K |
Net Income | -28.25M | -69.05M | -55.14M | -122.34M | -112.91M | -103.21M | -99.92M | -25.79M | -27.81M | -27.86M | -20.65M | -12.29M | -5.54M | -215K |
Selling & General & Admin | 25.3M | 24.47M | 22.1M | 18.84M | 15.85M | 11.16M | 8.47M | 4.56M | 3.51M | 2.86M | 1.92M | 1.39M | 749K | n/a |
Research & Development | 63.01M | 52.65M | 38.31M | 32.71M | 25.07M | 18.43M | 16.46M | 15.87M | 16.36M | 16.57M | 12.9M | 7.82M | 3.43M | n/a |
Other Expenses | -990K | 378K | 1.88M | 3.73M | 3.86M | 2.62M | 1.13M | 1.1M | 719K | 651K | 636K | 326K | 58K | n/a |
Operating Expenses | 87.95M | 78.14M | 62.3M | 55.28M | 44.77M | 32.2M | 26.06M | 22.16M | 21.21M | 20.71M | 16.08M | 9.54M | 4.23M | n/a |
Interest Expense | 2.99M | 2.99M | 2.8M | 3.2M | 3.89M | 4.34M | 4.95M | 4.33M | 3.27M | 2.4M | 1.23M | 689K | 313K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 60.83M | 78.14M | 62.3M | 55.28M | 44.77M | 32.2M | 26.06M | 22.16M | 21.21M | 20.71M | 16.08M | 9.54M | 4.23M | n/a |
Income Tax Expense | 248K | 29K | -19K | -51.74M | -53.21M | -53.23M | -53.2M | -1.45M | 51K | 51K | 51K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 51.02M | 50.98M | 45.11M | 44.17M | 39.44M | 23.2M | 31.3M | 15.81M | 15.81M | 15.81M | 15.81M | 15.81M | 15.81M | 15.81M |
Shares Outstanding (Diluted) | 51.02M | 50.98M | 45.11M | 44.17M | 39.44M | 23.2M | 31.3M | 15.81M | 15.81M | 15.81M | 15.81M | 15.81M | 15.81M | 15.81M |
EPS (Basic) | -0.32 | -1.21 | -1.19 | -3.8 | -3.74 | -3.64 | -3.55 | -1.44 | -1.52 | -1.52 | -1.16 | -0.63 | -0.29 | -0.01 |
EPS (Diluted) | -0.32 | -1.21 | -1.19 | -3.8 | -3.74 | -3.64 | -3.55 | -1.44 | -1.52 | -1.58 | -1.22 | -0.69 | -0.35 | -0.01 |
EBITDA | -24.41M | -65.69M | -52.04M | -118.87M | -108.76M | -98.67M | -94.77M | -21.25M | -24.34M | -25.28M | -19.08M | -11.33M | -5.01M | n/a |
EBIT | -51.8M | -66.03M | -52.36M | -119.16M | -109.01M | -98.88M | -94.95M | -21.43M | -24.53M | -25.43M | -19.19M | -11.38M | -5.01M | n/a |
Depreciation & Amortization | 267K | 345K | 323K | 289K | 250K | 209K | 175K | 178K | 188K | 151K | 105K | 53K | n/a | n/a |